Risk of hypertension in treatment-naive people with HIV (PWH) in the US receiving integrase strand inhibitors (INSTIs) versus non-nucleoside reverse transcriptase inhibitors (NNRTIs) or tenofovir alafenamide (TAF) versus non-TAF-based regimens: pooled analysis of blood pressure data from five clinical trials

被引:0
|
作者
Hsue, Priscilla Y. [1 ]
Waters, Laura [2 ]
Orkin, Chloe [3 ]
Tiraboschi, Juan Manuel [4 ]
Avihingsanon, Anchalee [5 ]
Marongiu, Andrea [6 ]
Whiteman, Andrew [7 ]
Tian, Yuan [7 ]
Nielson, Carrie M. [8 ]
Aizen, Keith [9 ]
Cohen, Cal [10 ]
Hindman, Jason T. [11 ]
Rockstroh, Juergen K. [12 ]
机构
[1] Univ Calif San Francisco, Div Cardiol, San Francisco, CA USA
[2] Cent & North West London NHS Fdn Trust, Mortimer Market Ctr, London, England
[3] Queen Mary Univ, Blizard Inst, London, England
[4] Bellvitge Univ Hosp, Dept Infect Dis, Barcelona, Spain
[5] Thai Red Cross AIDS Res Ctr, HIV Netherlands Australia Thailand Res Collaborat, Bangkok, Thailand
[6] Gilead Sci Ltd, Real World Evidence, Uxbridge, Middx, England
[7] Gilead Sci Inc, Clin Bioinformat & Exploratory Analyt, Foster City, CA USA
[8] Gilead Sci Inc, Real World Evidence, Foster City, CA USA
[9] Gilead Sci Inc, Patient Safety, Foster City, CA USA
[10] Gilead Sci Inc, Med Affairs, Foster City, CA USA
[11] Gilead Sci Inc, Clin, Foster City, CA USA
[12] Univ Bonn, Dept Med, Bonn, Germany
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P283
引用
收藏
页码:249 / 251
页数:3
相关论文
empty
未找到相关数据